KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Acquisitions (2023 - 2025)

Regeneron Pharmaceuticals (REGN) has disclosed Acquisitions for 3 consecutive years, with $300000.0 as the latest value for Q4 2025.

  • For Q4 2025, Acquisitions fell 97.39% year-over-year to $300000.0; the TTM value through Dec 2025 reached $14.8 million, down 77.71%, while the annual FY2025 figure was $3.3 million, 80.0% down from the prior year.
  • Acquisitions hit $300000.0 in Q4 2025 for Regeneron Pharmaceuticals, down from $3.0 million in the prior quarter.
  • Across five years, Acquisitions topped out at $51.1 million in Q3 2023 and bottomed at $300000.0 in Q4 2025.
  • Average Acquisitions over 3 years is $13.9 million, with a median of $3.8 million recorded in 2023.
  • Year-over-year, Acquisitions soared 202.63% in 2024 and then plummeted 97.39% in 2025.
  • Regeneron Pharmaceuticals' Acquisitions stood at $3.8 million in 2023, then skyrocketed by 202.63% to $11.5 million in 2024, then tumbled by 97.39% to $300000.0 in 2025.
  • According to Business Quant data, Acquisitions over the past three periods came in at $300000.0, $3.0 million, and $11.5 million for Q4 2025, Q3 2025, and Q4 2024 respectively.